Resultados de procura - Neerav Shukla
- Mostrando 1 - 20 Resultados de 35
- Go to Next Page
-
1
-
2
-
3
Oncogene Mutation Profiling of Pediatric Solid Tumors Reveals Significant Subsets of Embryonal Rhabdomyosarcoma and Neuroblastoma with Mutated Genes in Growth Signaling Pathways por Neerav Shukla, Nabahet Ameur, İsmail Yılmaz, Khédoudja Nafa, Chyau-Yueh Lau, Angela Marchetti, Laetitia Borsu, Frederic G. Barr, Marc Ladanyi
Publicado 2011Artigo -
4
TFE3 Fusions Activate MET Signaling by Transcriptional Up-regulation, Defining Another Class of Tumors as Candidates for Therapeutic MET Inhibition por Masumi Tsuda, Ian J. Davis, Pedram Argani, Neerav Shukla, Gaël McGill, Makoto Nagai, Tsuyoshi Saito, Marick Laé, David E. Fisher, Marc Ladanyi
Publicado 2007Artigo -
5
Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center por Michael V. Ortiz, Rachel Kobos, Michael F. Walsh, Emily K. Slotkin, Stephen S. Roberts, Michael F. Berger, Meera Hameed, David B. Solit, Marc Ladanyi, Neerav Shukla, Alex Kentsis
Publicado 2016Artigo -
6
Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia por Sanam Shahid, Kavitha Ramaswamy, Jessica Flynn, Audrey Mauguen, Karlo Perica, Jae H. Park, Christopher J. Forlenza, Neerav Shukla, Peter G. Steinherz, Steven Margossian, Jaap Jan Boelens, Nancy A. Kernan, Kevin J. Curran
Publicado 2021Artigo -
7
Mutational Inactivation of <i>STAG2</i> Causes Aneuploidy in Human Cancer por David A. Solomon, Taeyeon Kim, Laura A. Díaz-Martínez, Joshlean Fair, Abdel Elkahloun, Brent T. Harris, Jeffrey A. Toretsky, Steven A. Rosenberg, Neerav Shukla, Marc Ladanyi, Yardena Samuels, C. David James, Hongtao Yu, Jung-Sik Kim, Todd Waldman
Publicado 2011Artigo -
8
DNA Methylation–Based Classifier for Accurate Molecular Diagnosis of Bone Sarcomas por Synphen Wu, Benjamin T. Cooper, Fang Bu, Christopher Bowman, J. Keith Killian, Jonathan Serrano, Shiyang Wang, Twana M. Jackson, Daniel Gorovets, Neerav Shukla, Paul A. Meyers, David J. Pisapia, Richard Görlick, Marc Ladanyi, Kristen Thomas, Matija Snuderl, Matthias A. Karajannis
Publicado 2017Artigo -
9
Clinical Genomic Sequencing of Pediatric and Adult Osteosarcoma Reveals Distinct Molecular Subsets with Potentially Targetable Alterations por Yoshiyuki Suehara, Deepu Alex, Anita S. Bowman, Sumit Middha, Ahmet Zehir, Debyani Chakravarty, Lu Wang, George Jour, Khédoudja Nafa, Takuo Hayashi, Achim A. Jungbluth, Denise Frosina, Emily K. Slotkin, Neerav Shukla, Paul A. Meyers, John H. Healey, Meera Hameed, Marc Ladanyi
Publicado 2019Artigo -
10
Plasma DNA-Based Molecular Diagnosis, Prognostication, and Monitoring of Patients With <i>EWSR1</i> Fusion-Positive Sarcomas por Neerav Shukla, Juber Patel, Heather Magnan, Ahmet Zehir, Daoqi You, Jiabin Tang, Fanli Meng, Aliaksandra Samoila, Emily K. Slotkin, Srikanth R. Ambati, Alexander J. Chou, Leonard H. Wexler, Paul A. Meyers, Ellinor I.B. Peerschke, Agnès Viale, Michael F. Berger, Marc Ladanyi
Publicado 2017Artigo -
11
Cell‐free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience por Prachi Kothari, Francesco Marass, Julie L. Yang, Caitlin M. Stewart, Dennis Stephens, Juber Patel, Maysun Hasan, Xiaohong Jing, Fanli Meng, Jeanette Enriquez, Kety Huberman, Agnès Viale, Jasmine H. Francis, Michael F. Berger, Neerav Shukla, David H. Abramson, Ira J. Dunkel, Dana W.Y. Tsui
Publicado 2020Artigo -
12
A recurrent novel <i>MGA–NUTM1</i> fusion identifies a new subtype of high-grade spindle cell sarcoma por Daniel Diolaiti, Filemon S. Dela Cruz, Gunes Gundem, Nancy Bouvier, Mathieu Boulad, Yanming Zhang, Alexander J. Chou, Ira J. Dunkel, Rashesh Sanghvi, Minita Shah, Heather Geiger, Sadia Rahman, Vanessa Felice, Kazimierz O. Wrzeszczyński, Robert B. Darnell, Cristina R. Antonescu, Christopher A. French, Elli Papaemmanuil, Andrew L. Kung, Neerav Shukla
Publicado 2018Artigo -
13
Impact of surgery, radiation and systemic therapy on the outcomes of patients with dendritic cell and histiocytic sarcomas por Mrinal M. Gounder, Ved Desai, Deborah Kuk, Narasimhan P. Agaram, Maria E. Arcila, Benjamin H. Durham, Mary Louise Keohan, Mark A. Dickson, Sandra P. D’Angelo, Neerav Shukla, Craig H. Moskowitz, Ariela Noy, Robert G. Maki, Diego Adrianzen Herrera, Armando Sánchez, Anita Krishnan, Andrew Pourmoussa, Li-Xuan Qin, William D. Tap
Publicado 2015Artigo -
14
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors por Neerav Shukla, Romel Somwar, Roger S. Smith, Sri Ambati, Stanley Munoz, Melinda S. Merchant, Pádraig D’Arcy, Xin Wang, Rachel Kobos, Christophe Antczak, Bhavneet Bhinder, David Shum, Constantin Radu, Guangbin Yang, Barry S. Taylor, Charlotte K.Y. Ng, Britta Weigelt, Inna Khodos, Elisa de Stanchina, Jorge S. Reis‐Filho, Ouathek Ouerfelli, Stig Linder, Hakim Djaballah, Marc Ladanyi
Publicado 2016Artigo -
15
Successful Targeted Therapy of Refractory Pediatric <i>ETV6-NTRK3</i> Fusion-Positive Secretory Breast Carcinoma por Neerav Shukla, Stephen S. Roberts, Mollah Obayedullah Baki, Qazi Danish Mushtaq, Paul E. Goss, Ben Ho Park, Gunes Gundem, Ken Tian, Heather Geiger, Kristie Redfield, Gerald Behr, Ryma Benayed, Ahmet Zehir, Jaclyn F. Hechtman, Robert B. Darnell, Elli Papaemmanuil, Marc Ladanyi, Nora Ku, Andrew L. Kung, José Baselga, Alexander Drilon, David M. Hyman
Publicado 2017Artigo -
16
Characterization of on-target adverse events caused by TRK inhibitor therapy por D. Liu, James Flory, Andrew Lin, Michael Offin, Christina J. Falcon, Yonina R. Murciano‐Goroff, Ezra Rosen, Robin Guo, Ellen M. Basu, Bob T. Li, James J. Harding, Gopa Iyer, Komal Jhaveri, Mrinal M. Gounder, Neerav Shukla, Stephen S. Roberts, Julia Glade Bender, Lauren A. Kaplanis, Alison M. Schram, David M. Hyman, Alexander Drilon
Publicado 2020Artigo -
17
A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations por Shinji Kohsaka, Neerav Shukla, Nabahet Ameur, Tatsuo Ito, Charlotte K.Y. Ng, Lu Wang, Diana Lim, Angela Marchetti, Agnès Viale, Mono Pirun, Nicholas D. Socci, Li-Xuan Qin, Raf Sciot, Julia A. Bridge, Samuel Singer, Paul A. Meyers, Leonard H. Wexler, Frederic G. Barr, Snjezana Doğan, Jonathan A. Fletcher, Jorge S. Reis‐Filho, Marc Ladanyi
Publicado 2014Artigo -
18
Clonal hematopoiesis in survivors of childhood cancer por Danielle Novetsky Friedman, Irenaeus C.C. Chan, Chaya S. Moskowitz, Shanita Li, Kimberly L. Turner, Jie Liu, Nancy Bouvier, Michael F. Walsh, Barbara Spitzer, Andrew L. Kung, Michael F. Berger, Megan A. Cooper, Iskra Pusic, Geoffrey L. Uy, Daniel C. Link, Todd E. Druley, Luis A. Díaz, Ross L. Levine, Neerav Shukla, Kelly L. Bolton
Publicado 2023Artigo -
19
The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia por Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio, Branko Cuglievan, Richard M. Stone, Martha Arellano, Michael J. Thirman, Manish R. Patel, David S. Dickens, Shalini Shenoy, Neerav Shukla, Hagop M. Kantarjian, Scott A. Armstrong, Florian Perner, Jennifer A. Perry, Galit Rosen, Rebecca G. Bagley, Michael L. Meyers, Peter Ordentlich, Yu Gu, Vinit Kumar, Steven G. Smith, Gerard M. McGeehan, Eytan M. Stein
Publicado 2023Artigo -
20
Clonal evolution during metastatic spread in high-risk neuroblastoma por Gunes Gundem, Max F. Levine, Stephen S. Roberts, Irene Y. Cheung, Juan S. Medina-Martínez, Yi Feng, Juan Arango Ossa, Loic Chadoutaud, Mathieu Rita, Georgios Asimomitis, Joe Zhou, Daoqi You, Nancy Bouvier, Barbara Spitzer, David B. Solit, Filemon S. Dela Cruz, Michael P. LaQuaglia, Brian H. Kushner, Shakeel Modak, Neerav Shukla, Christine A. Iacobuzio‐Donahue, Andrew L. Kung, Nai‐Kong V. Cheung, Elli Papaemmanuil
Publicado 2023Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Medicine
Gene
Genetics
Internal medicine
Pathology
Cancer research
Oncology
Cancer
Sarcoma
Bioinformatics
Computational biology
Mutation
Precision medicine
Genome
Leukemia
Clinical trial
Fusion gene
Genomics
Immunotherapy
Signal transduction
Targeted therapy
Astrobiology
Biochemistry
Cell biology
Chemotherapy
Computer science
Disease
Embryonal rhabdomyosarcoma
Gene expression